CAMBRIDGE, Mass., Aug. 7, 2007 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the detailed structural analysis of complex mixture drugs, today announced its financial results for the second quarter and six months ended June 30, 2007.
